Literature DB >> 8313431

Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy.

R J Hajjar1, R Liao, J B Young, F Fuleihan, M G Glass, J K Gwathmey.   

Abstract

OBJECTIVE: With the recent availability of human myocardium, many animal models have been shown to be unsuitable as models of human heart failure. The aim of this study was to describe the pathophysiological changes in a model of dilated cardiomyopathy in turkey poults and to compare them to results obtained from failing human hearts.
METHODS: After receiving furazolidone for 2-3 weeks, animals developed cardiomyopathy (Fz-DCM) and were studied at the whole heart and isolated muscle level. Myofibrillar ATPase activity and noradrenaline turnover were determined in tissue homogenates in failing and non-failing control hearts.
RESULTS: Fz-DCM animals had greater heart weights, heart weight/body weight ratios, and end diastolic volumes. Fractional shortening of the left ventricle and systolic blood pressures were reduced (p < 0.01) in myopathic animals. Isolated perfused hearts had lower peak developed pressures (p < 0.01). Isolated muscle preparations showed no significant differences in peak twitch forces between control and Fz-DCM muscles at a 1 Hz stimulation rate. The relationship between force and frequency of stimulation was positive in control muscles up to 1.7 Hz, whereas in Fz-DCM muscles the relationship was sharply negative above 1 Hz. Time to 80% relaxation was markedly slower in the Fz-DCM muscles. Although [Ca2+]o responsiveness was similar for Fz-DCM and normal animals, responsiveness to isoprenaline was significantly reduced in Fz-DCM hearts. Cardiomyopathic animals displayed diminished noradrenaline content in the left ventricle. Fractional noradrenaline turnover was higher (p < 0.05) in the cardiomyopathic birds. In skinned fibre preparations from control and Fz-DCM hearts calcium activations were similar. Maximum myofibrillar ATPase activities were, however, significantly lower in myopathic animals and myofibrillar protein content was reduced by 25%.
CONCLUSIONS: In this model of dilated cardiomyopathy: (1) relaxation is markedly prolonged; (2) the response to beta adrenergic stimulation is diminished; (3) Mg-ATPase activities and myofibrillar protein content are reduced; and (4) sympathetic activity in the heart is markedly increased with depletion of noradrenaline stores. Furthermore, a reduction in tissue noradrenaline content per se is a misleading index of the dynamic state of cardiac noradrenaline stores. With its similarities to human cardiomyopathy, this model promises to provide new insights into the pathophysiology and progression of dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8313431     DOI: 10.1093/cvr/27.12.2212

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Intracellular calcium and the relationship to contractility in an avian model of heart failure.

Authors:  C S Kim; A J Davidoff; T M Maki; A A Doye; J K Gwathmey
Journal:  J Comp Physiol B       Date:  2000-06       Impact factor: 2.200

2.  Calcium handling proteins: structure, function, and modulation by exercise.

Authors:  Jamille Locatelli; Leonardo V M de Assis; Mauro C Isoldi
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 3.  Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research.

Authors:  B H Ali
Journal:  Vet Res Commun       Date:  1999-10       Impact factor: 2.459

4.  A pilot study of a new chicken model of alcohol-induced cardiomyopathy.

Authors:  N Morris; C S Kim; A A Doye; R J Hajjar; N Laste; J K Gwathmey
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

5.  Meta-analysis of the association of enteroviruses with human heart disease.

Authors:  C Baboonian; T Treasure
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

Review 6.  An experimental approach to study the function of mitochondria in cardiomyopathy.

Authors:  Youn Wook Chung; Seok-Min Kang
Journal:  BMB Rep       Date:  2015-10       Impact factor: 4.778

7.  Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy.

Authors:  Ming Zhang; Jin Wei; Hu Shan; Hao Wang; Yanhe Zhu; Jiahong Xue; Lin Lin; Rui Yan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

8.  Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.

Authors:  Chukwuka C Okafor; Cynthia Perreault-Micale; Roger J Hajjar; Djamel Lebeche; Klara Skiroman; George Jabbour; Angelia A Doye; Michael X Lee; Nancy Laste; Judith K Gwathmey
Journal:  BMC Physiol       Date:  2003-07-21

Review 9.  Calcium and Heart Failure: How Did We Get Here and Where Are We Going?

Authors:  Natthaphat Siri-Angkul; Behzad Dadfar; Riya Jaleel; Jazna Naushad; Jaseela Parambathazhath; Angelia A Doye; Lai-Hua Xie; Judith K Gwathmey
Journal:  Int J Mol Sci       Date:  2021-07-09       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.